Anika Therapeutics (NQ: ANIK )
42.11 USD -0.52 (-1.22%) Streaming Delayed Price Updated: 4:00 PM EDT, Oct 26, 2021 Add to My Watchlist
All news about Anika Therapeutics
A company's own top management tend to have the best inside view into the business, so when company officers make major buys, investors are wise to take notice. Presumably the only reason an insider...
Anika Launches the WristMotion® Total Wrist Arthroplasty System at the American Society for Surgery of the Hand Annual Meeting
September 30, 2021
Designed to preserve natural motion and maximize stability, the WristMotion® Total Wrist Arthroplasty System provides an advanced solution for wrist arthritis and an alternative to wrist fusion
Anika to Participate in the Morgan Stanley 19th Annual Global Healthcare Conference
September 07, 2021
Anika to Debut Joint Preservation Portfolio at the 2021 AAOS Annual Meeting
September 01, 2021
Anika, now combined with Arthrosurface and Parcus Medical, meets the evolving unmet needs of surgeons in the global joint preservation market
Return on Capital Employed Insights for Anika Therapeutics
August 23, 2021
After pulling data from Benzinga Pro it seems like during Q2, Anika Therapeutics (NASDAQ:ANIK) earned $9.18 million, a 629.73% increase ...
Anika Therapeutics, inc (ANIK) Q2 2021 Earnings Call Transcript
August 06, 2021
Anika Reports Second Quarter 2021 Financial Results
August 05, 2021
The Daily Biotech Pulse: Merck Reports Positive Keytruda Readout, Moderna Slips Despite Q2 Beat, Bayer To Buy Vividion For Up To $2B, GlycoMimetics Gets New CEO
August 05, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ...
The Week Ahead In Biotech (Aug. 1-7): Biopharma Earnings Pick Up Pace, Eton Awaits FDA Decision, Focus On Pending Clinical Readouts and IPOs
August 01, 2021
Biotech stocks showed a lack of direction in the week endingJuly 30 amid earnings releases from big pharma companies. Most ...
Upgrades According to Citigroup, the prior rating for Alcoa Corp (NYSE:AA) was changed from Neutral to Buy. In the ...
There's an old saying on Wall Street about insider buying: there are many possible reasons to sell a stock, but only one reason to buy. Back on May 18, Anika Therapeutics Inc.'s Director, John B..
Notable Friday Option Activity: TSLA, VRTX, ANIK
June 11, 2021
Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Tesla Inc (TSLA), where a total of 1.0 million contracts have traded so far, representing...
The Daily Biotech Pulse: FDA Nod For Novartis, iRhythm CEO Quits Abruptly, Moderna Inks Vaccine Supply Agreements
June 02, 2021
The Implied Analyst 12-Month Target For PSCH
March 24, 2021
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and...
From ETF Channel
Recap: Anika Therapeutics Q4 Earnings
March 04, 2021
Shares of Anika Therapeutics (NASDAQ:ANIK) were flat in after-market trading after the company reported Q4 results. Quarterly ...
The Daily Biotech Pulse: FDA Nod For Pfizer, Kiniksa Rises On Commercialization Pact With Regeneron, Bio-Techne To Buy Diagnostic Company
March 04, 2021